Ketorolac Tromethamine Injection, Solution
Product Images NDC 51662-1702

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ketorolac Tromethamine (NDC 51662-1702). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (51662 1702 Structure)

Chemical structure of ketorolac tromethamine, showing the molecular composition and arrangement of atoms characteristic of this active pharmaceutical ingredient.*

FDA Label Image

Label (51662 1702 Table 1)

A data table presenting pharmacokinetic parameters of ketorolac tromethamine across different administration routes and doses, including oral 10 mg, intramuscular 15 mg, 30 mg, and 60 mg, and intravenous bolus 15 mg and 30 mg. Parameters listed include bioavailability, Tmax, Cmax for single-dose and steady state, Cmin, Cavg at steady state, and volume of distribution (Vp).*

FDA Label Image

Table (51662 1702 Table 2)

Table presenting total clearance and terminal half-life data of ketorolac tromethamine injection and oral forms across various subject groups, including normal subjects, healthy elderly subjects, patients with hepatic dysfunction, renal impairment, and renal dialysis patients. Data includes mean values and ranges for intramuscular and oral administration routes.*

FDA Label Image

Label (51662 1702 1 Vial1)

A barcode label for KETOROLAC TROMETHAMINE injection, solution, 30 mg/mL, distributed by HF Acquisition Co., LLC in Mukilteo, WA. The label includes several numeric codes and a QR code, along with the text 'RX ONLY' and a note to see the manufacturer's insert.*

FDA Label Image

Label (51662 1702 2 Pouch)

Label for Ketorolac Tromethamine Injection USP, 60 mg per 2 mL (30 mg/mL) in a 2 mL vial. The label includes NDC 51662-1702-2, lot number, expiration date, and manufacturer information for HF Acquisition Co LLC, DBA HealthFirst. The medication is indicated for intramuscular use only, with additional storage and content details noted.*

FDA Label Image

Label (51662 1702 3 Case)

This image shows a drug facts or text panel for Ketorolac Tromethamine Injection USP, 30 mg/mL strength, supplied as a 2 mL vial box of 25. It includes the NDC 51662-1702-3, lot number, expiration date, and detailed usage instructions indicating intramuscular administration only. The text also lists ingredients and storage conditions, distributed by HF Acquisition Co., LLC.*

FDA Label Image

Label (63323 162 03 Ketorolac Vial Label Image 2)

Label for Ketorolac Tromethamine Injection, USP, showing a strength of 60 mg per 2 mL (30 mg per mL) in a 2 mL single dose vial. The label specifies intramuscular use only and includes dosage instructions to see the package insert. The labeler Fresenius Kabi and an NDC code are visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.